InsidersTradesSigma
AKANDA CORP. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the AKANDA CORP. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €8.7m. The latest transaction was reported on 20 January 2026 (Acquisition). Among the most active insiders: HRT FINANCIAL LP. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€34,904
1 ops.
Buy Volume
€8,743
1 ops.
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 January 2026
Declarations2 total
29,036 shares@ US$1.4080.0% of flowClass A SharesSEC:0001475597-26-000002:0
Canonical exit: 15 Apr 2026 (T+90)
7,868 shares@ US$1.2920.0% of flowClass A SharesSEC:0001475597-26-000002:1
2 of 2 declarations
About AKANDA CORP.
AKANDA CORP. is a company listed on the XNAS market. It specializes in the health and pharmaceutical sector.